Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New benzimidazole-based gastric antisecretory agents claimed by Altana Pharma

Aug. 5, 2004

Merck KGaA describes new derivatives of the kappa opioid agonist asimadoline

Aug. 5, 2004

Toll-like receptor 4 antagonist promising against IBD in mice

Aug. 3, 2004

Phase II study evaluates IDN-6556 in HCV patients

Aug. 3, 2004

Phase I results of spi-VEC vaccine for hepatitis B

July 30, 2004

Launch of Axid oral solution

July 30, 2004

URSO 500 mg approved for primary biliary cirrhosis

July 28, 2004

Intercell's phase II study of hepatitis C vaccine meets endpoints

July 28, 2004

Gilead claims new anti-HBV/HDV agents

July 28, 2004

FDA approves Alinia tablets for adults

July 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...